ÈÑÒÈÍÀ

Kukharchuk

Ñîàâòîðû: Ñòàìáîëüñêèé Ä.Â., Malyshev P., Ìåøêîâ À.Í., Meshkov A.N., ßðîâàÿ Å.Á., Êàòêîâà Å.Â., Êóòîâ Ä.Ê., Ñóëèìîâ À.Â., Ñóëèìîâ Â.Á., Àôàíàñüåâà Ì.È., Êîíîâàëîâà Â.Â., Ïîêðîâñêèé Ñ.Í., Ñàâêèí È.À. ïîêàçàòü ïîëíîñòüþ..., Rozhkova T., Solovjova Y., Tvorogovà Ì., Ñóñåêîâ À.Â., Chepetova T.V., Hasanova Z.B.

5 ñòàòåé, 9 äîêëàäîâ íà êîíôåðåíöèÿõ, 1 òåçèñû äîêëàäà

Êîëè÷åñòâî öèòèðîâàíèé ñòàòåé â æóðíàëàõ ïî äàííûì Web of Science: 21

IstinaResearcherID (IRID): 993166

Äåÿòåëüíîñòü ñòèëü:  îáû÷íûé | ÃÎÑÒ | plain | abbrv | acm | alpha | amsalpha | amsplain | apalike | ieeetr | siam

• Ñòàòüè â æóðíàëàõ

  • 
    • 2015 Genome-wide analysis of genetic associations for prediction of polygenic hypercholesterolemia with bayesian networks
    • Sulimov A.V., Meshkov A.N., Savkin I.A., Katkova E.V., Kutov D.C., Hasanova Z.B., Konovalova N.V., Kukharchuk V.V., Sulimov V.B.
    • â æóðíàëå Journal of Computational and Engineering Mathematics, òîì 2, ? 4, ñ. 11-26
  • 
    • 2007 The prevalence of ApoB-100 R3500Q mutation in Russian patients with moderate and severe hypercholesterolemia Atherosclerosis supliments
    • Meshkov A.N., Chepetova T.V., Stambolsky D.V., Malyshev P.P., Kukharchuk V.N.
    • â æóðíàëå Atherosclerosis Supplements, èçäàòåëüñòâî Elsevier BV (Netherlands), òîì 8, ? 1, ñ. 53-53
  • 
    • 2004 Novel LDL-receptor gene mutations in Russian patients with familial hypercholesterolaemia
    • Meshkov A., Stambolsky D., Kukharchuk V., Malyshev P.
    • â æóðíàëå Atherosclerosis Supplements, èçäàòåëüñòâî Elsevier BV (Netherlands), òîì 5, ? 1, ñ. 88-88
  • 
    • 2004 Screening for the apolipoprotein B-100 gene mutations by single-strand conformation polymorphism analysis in russian subjects with a clinical diagnosis of familial hypercholesterolemia
    • Malyshev P., Meshkov A., Stambolsky D., Kukharchuk V.
    • â æóðíàëå Atherosclerosis Supplements, èçäàòåëüñòâî Elsevier BV (Netherlands), òîì 5, ? 1, ñ. 86-86
  • 
    • 1997 The use of long term results of lipoprotein (a) apheresis to study lipoprotein (a) metabolism in man
    • Yarovaya E.B., Sussekov A.V., Afanasieva O.I., Pokrovsky S.N., Kukharchuk V.V.
    • â æóðíàëå Prostaglandins Leukotrienes and Essential Fatty Acids, èçäàòåëüñòâî Churchill Livingstone (United States), òîì 57, ? 4, ñ. 524-524

• Äîêëàäû íà êîíôåðåíöèÿõ

  • • 2001 Cardiovascular Risk Profile in Adult Probands according to Fasting Plasma Triglyceride Concentration
    • Àâòîðû: Yarovaya Ye, Rozhkova T., Solovjova Ye, Tvorogova M., Sussekov A., Kukharchuk V.
    • The 72th Congress of European Atherosclerosis Society, Glasgow, May 20-23, 2001, Glasgow, UK, 2001
  • • 2001 Positive Family History ia a Risk Factor for CVD: The Moscow Region Family Study
    • Àâòîðû: Yarovaya Ye, Rozhkova T., Solovjova Ye, Tvorogovà Ì., Kukharchuk V.
    • The 5th International Heart Health Conference, May 27-31, 2001, Osaka, Japan, Osaka, Japan, ßïîíèÿ, 2001
  • • 2001 Risk Factor Profiles for CHD and Arterial Hypertention in Adult Probands
    • Àâòîðû: Yarovaya Y., Rozhkova T., Solovjova Y., Tvorogova M., Sussekov, Kukharchuk V.
    • The International Symposium on Medicine in the New Millennium ?Towards Better Prediction and Prevention of Disease? (June 1-2, 2001, Kyoto, Japan) , 2001
  • • 1998 Effect of LDL and Lp(a) apheresis on ratio of plasma lipid parameters
    • Àâòîðû: Yarovaya E.B., Bolshakova N.V., Sussekov A.V., Afanasieva O.I., Pokrovsky S.N., Kukharchuk V.V.
    • European Atherosclerosis Society. 70th EAS Congress. Geneva, Switzerland, September 6-9, 1998., Geneva, Switzerland, Øâåéöàðèÿ, 1998
  • • 1997 Effect of repeated Lp(a) apheresis on metabolic parameters of lipoprotein(a)
    • Àâòîðû: Yarovaya Ye B., Sussekov A.V., Afanasieva O.I., Pokrovsky S.N., Kukharchuk V.V.
    • 11th International Symposium on Atherosclerosis. Paris, 5-9 October, 1997, Paris, France, Ôðàíöèÿ, 1997
  • • 1997 Model fitting to study Lp(a) kinetics in vivo using Lp(a) apheresis results
    • Àâòîðû: Yarovaya E.B., Sussekov A.V., Afanasieva O.I., Pokrovsky S.N., Kukharchuk V.V.
    • The 9th International Dresden Symposium on Lipoproteins and Atherosclerosis. Dresden, Germany, June 27-29,1997, Dresden, Germany, Ãåðìàíèÿ, 1997
  • • 1996 The use of long term LP (a) apheresis results in the study of LP (a) metabolism in man
    • Àâòîðû: Yarovaya Ye B., Sussekov A.V., Afanasieva O.I., Pokrovsky S.N., Kukharchuk V.V.
    • 66th Congress of the European Atherosclerosis Society. Floreance, Italy, July 13-17, 1996 , Floreance, Italy, Èòàëèÿ, 1996
  • • 1996 The use of long term results of lipoprotein (a) apheresis to study lipoprotein (a) metabolism in man
    • Àâòîðû: Yarovaya E.B., Sussekov A.V., Afanasieva O.I., Pokrovsky S.N., Kukharchuk V.V.
    • Abstracts. ETRO (European Thrombosis Research Organisation)-ISSFAL (International Society for the Study of Fatty Acids and Lipids) symposium ?Lipids, membranes and thrombosis?. July 10-13,, Maastricht, The Netherlands, Íèäåðëàíäû, 1996
  • • 1995 Model analysis of different hypotheses of lipopritein (a) influx rate into plasma in vivo studies
    • Àâòîðû: Rostapshova T.V., Yarovaya Å.B., Schurigina N.P., Afanasieva O.I., Pokrovsky S.N., Kukharchuk V.V.
    • 64th EAS (European Ath-erosclerosis Society) Congress. Utrecht, the Netherlands, June 10-13, 1995., Utrecht, the Netherlands, Íèäåðëàíäû, 1995

• Òåçèñû äîêëàäîâ

  • • 2001 Risk Factor Profiles for CHD and Arterial Hypertention in Adult Probands
    • Yarovaya Y., Rozhkova T., Solovjova Y., Tvorogova M., Kukharchuk
    • â ñáîðíèêå Abstracts of the International Symposium on Medicine in the New Millennium ?Towards Better Prediction and Prevention of Disease? (June 1-2, 2001, Kyoto, Japan), ìåñòî èçäàíèÿ Kyoto, Japan, òåçèñû, ñ. 31-31